Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Immudicon Logo
Immudicon Growth Score
83
CB Rank
440468
Heat Score
75
Immudicon is a biotechnology company that creates complement-based biologics which targets and localizes immune cells to tumors.
Founded
obfuscation
PrivateSeed Cambridge, Massachusetts, United States1-10 www.immudicon.com/
Biotechnology
Health Care
Therapeutics
Overview

Immudicon
Growth Score
83
Heat Score
75

Growth Score83
-5 pts
in past quarter
Heat Score 75
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Immudicon

CB Rank
440468
Immudicon is a biotechnology company that creates complement-based biologics which targets and localizes immune cells to tumors.
Founded
obfuscation
PrivateSeed Cambridge, Massachusetts, United States1-10 www.immudicon.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
About the Company
Immudicon is a biotechnology company that creates complement-based biologics which targets and localizes immune cells to tumors. The platform modulates chemical barriers within the tumor microenvironment that create an immunosuppressive shield around the tumor. Immudicon was founded in 2011 and is based in Washington, D.C.
Phone Number +117033893339
Contact Email info@immudicon.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Complement-based Biologics
Biologic therapies that target and localize immune cells to tumors using the complement system.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed
obfuscation
Seed Round - Immudicon Logo
Seed Round - Immudicon
1
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Dorm Room Fund Logo
Dorm Room Fund
No
Seed Round - Immudicon Logo
Seed Round - Immudicon
—
Dorm Room Fund Logo
Dorm Room Fund
No
Seed Round - Immudicon Logo
Seed Round - Immudicon
—
Dorm Room Fund Logo
Dorm Room Fund
No
Seed Round - Immudicon Logo
Seed Round - Immudicon
—
Dorm Room Fund Logo
Dorm Room Fund
No
Seed Round - Immudicon Logo
Seed Round - Immudicon
—
Dorm Room Fund Logo
Dorm Room Fund
No
Seed Round - Immudicon Logo
Seed Round - Immudicon
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$71.8KThis year, Immudicon is projected to spend $71.8K on IT, according to Aberdeen.

Actively Used Products

15Immudicon uses 15 technology products and services including HTML5, Vimeo, and  Google Tag Manager, according to G2 Stack.

Active Website Tech Count

3Immudicon is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Immudicon's headquarters? Immudicon is located in Cambridge, Massachusetts, United States.Who invested in Immudicon? Immudicon is funded by Dorm Room Fund.When was the last funding round for Immudicon? Immudicon closed its last funding round on
obfuscation
from a Seed round.Who are Immudicon's competitors? Alternatives and possible competitors to Immudicon may include Cue Biopharma, ImmuneBridge, and  Normunity.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|